Marina Bagnoli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial.
Journal: NPJ precision oncology
Published: June 05, 2025
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial.
Journal: ESMO open
Published: July 03, 2024
Impact of Cold Ischemia on the Stability of 1H-MRS-Detected Metabolic Profiles of Ovarian Cancer Specimens.
Journal: Journal of proteome research
Published: December 18, 2023
The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis.
Journal: Frontiers in cell and developmental biology
Published: September 27, 2022
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 26, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.
Journal: Diagnostics (Basel, Switzerland)
Published: July 18, 2022
Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer.
Journal: Frontiers in oncology
Published: April 19, 2022
Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 02, 2021
Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets.
Journal: Cancers
Published: February 02, 2021
MiREDiBase, a manually curated database of validated and putative editing events in microRNAs.
Journal: Scientific data
Published: January 11, 2021
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 22, 2020
Last Updated: 09/26/2026